Jeph Herrin, PhD
Articles
June 17th 2015
Changing Trends in Type 2 Diabetes Mellitus Treatment Intensification, 2002-2010
Rozalina G. McCoy, MD Yuanhui Zhang, PhD Jeph Herrin, PhD Brian T. Denton, PhD Jennifer E. Mason, PhD Victor M. Montori, MD Steven A. Smith, MD Nilay D. Shah, PhD
Glycemic control can lower the risk of diabetes-related complications, and delayed treatment intensification can impede optimal diabetes care.This study examines trends in hyperglycemia treatment intensification between 2002 and 2010.
Latest Updated Articles
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: August 6th 2024 | Updated: September 17th 2024
Rising Costs Lead Insurers to Drop Weight Loss Drug Coverage, Further Increasing Patient Burden
Published: August 16th 2024 | Updated: September 17th 2024
How Can We Improve Obesity Care in 2024 and Beyond?
Published: September 12th 2024 | Updated: September 17th 2024
The American Journal of Managed Care® Announces Lisa Rotenstein, M.D., MBA, as the Recipient of the Seema S. Sonnad Emerging Leader in Managed Care Research Award
Published: April 23rd 2024 | Updated: September 17th 2024
The American Journal of Managed Care® Announces Call for Manuscript Submissions for the 14th Annual Health Information Technology Special Issue
Published: September 10th 2024 | Updated: September 17th 2024
Different Options for Different People: Dr Bellinda King-Kallimanis Explores the State of Patient Education in Lung Cancer
